LifeMD Inc (LFMD) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.80 is considered Undervalued compared with the five-year average of -19.04. The fair price of LifeMD Inc (LFMD) is between 25.79 to 30.48 according to relative valuation method. Compared to the current price of 2.89 USD , LifeMD Inc By Undervalued By 88.79%.

Relative Value

Fair Zone

25.79-30.48

Current Price：2.89

88.79%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is LifeMD Inc (LFMD) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

LifeMD Inc (LFMD) has a current Price-to-Book (P/B) ratio of 123.71. Compared to its 3-year average P/B ratio of -66.34, the current P/B ratio is approximately -286.48% higher. Relative to its 5-year average P/B ratio of -260.08, the current P/B ratio is about -147.57% higher. LifeMD Inc (LFMD) has a Forward Free Cash Flow (FCF) yield of approximately 6.37%. Compared to its 3-year average FCF yield of -0.08%, the current FCF yield is approximately -7757.92% lower. Relative to its 5-year average FCF yield of -12.03%, the current FCF yield is about -152.91% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for LFMD competitors is 29.76, providing a benchmark for relative valuation. LifeMD Inc Corp (LFMD.O) exhibits a P/S ratio of 0.80, which is -97.31% above the industry average. Given its robust revenue growth of 12.95%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of LFMD increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of LFMD in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is LFMD currently overvalued or undervalued?

What is LifeMD Inc (LFMD) fair value?

LFMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of LifeMD Inc (LFMD) is between 25.79 to 30.48 according to relative valuation method.

How does LFMD's valuation metrics compare to the industry average?

The average P/S ratio for LFMD's competitors is 29.76, providing a benchmark for relative valuation. LifeMD Inc Corp (LFMD) exhibits a P/S ratio of 0.80, which is -97.31% above the industry average. Given its robust revenue growth of 12.95%, this premium appears unsustainable.

What is the current P/B ratio for LifeMD Inc (LFMD) as of Mar 02 2026?

As of Mar 02 2026, LifeMD Inc (LFMD) has a P/B ratio of 123.71. This indicates that the market values LFMD at 123.71 times its book value.

What is the current FCF Yield for LifeMD Inc (LFMD) as of Mar 02 2026?

As of Mar 02 2026, LifeMD Inc (LFMD) has a FCF Yield of 6.37%. This means that for every dollar of LifeMD Inc's market capitalization, the company generates 6.37 cents in free cash flow.

What is the current Forward P/E ratio for LifeMD Inc (LFMD) as of Mar 02 2026?

As of Mar 02 2026, LifeMD Inc (LFMD) has a Forward P/E ratio of -9.78. This means the market is willing to pay $-9.78 for every dollar of LifeMD Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for LifeMD Inc (LFMD) as of Mar 02 2026?

As of Mar 02 2026, LifeMD Inc (LFMD) has a Forward P/S ratio of 0.80. This means the market is valuing LFMD at $0.80 for every dollar of expected revenue over the next 12 months.

LFMD Valuation